Alrijne Ziekenhuis, locatie Leiderdorp

Public research footprint of Alrijne Ziekenhuis, locatie Leiderdorp, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Most-studied conditions

Atherosclerosis Cardiovascular Disease · Chronic Kidney Disease · Cardiovascular Diseases · Lipoprotein(a)

Recently updated registry entries

NCT07613294 — A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With… (Recruiting)
NCT07241390 — A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With… (Recruiting)
NCT06008756 — Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study… (Active Not Recruiting)

Work at Alrijne Ziekenhuis, locatie Leiderdorp?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.